These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27442811)
41. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293 [TBL] [Abstract][Full Text] [Related]
42. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016 [TBL] [Abstract][Full Text] [Related]
43. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status. Du E; Mazul AL; Farquhar D; Brennan P; Anantharaman D; Abedi-Ardekani B; Weissler MC; Hayes DN; Olshan AF; Zevallos JP Laryngoscope; 2019 Nov; 129(11):2506-2513. PubMed ID: 30637762 [TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Sivars L; Näsman A; Tertipis N; Vlastos A; Ramqvist T; Dalianis T; Munck-Wikland E; Nordemar S Cancer Med; 2014 Apr; 3(2):376-84. PubMed ID: 24510528 [TBL] [Abstract][Full Text] [Related]
45. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Troy JD; Weissfeld JL; Youk AO; Thomas S; Wang L; Grandis JR Head Neck Pathol; 2013 Dec; 7(4):344-55. PubMed ID: 23645351 [TBL] [Abstract][Full Text] [Related]
47. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression. Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036 [TBL] [Abstract][Full Text] [Related]
48. Eps8 expression is significantly lower in p16 Nasri E; Wiesen LB; Knapik JA; Fredenburg KM Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665 [TBL] [Abstract][Full Text] [Related]
49. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228 [TBL] [Abstract][Full Text] [Related]
50. Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. Cohen EEW; Licitra LF; Burtness B; Fayette J; Gauler T; Clement PM; Grau JJ; Del Campo JM; Mailliez A; Haddad RI; Vermorken JB; Tahara M; Guigay J; Geoffrois L; Merlano MC; Dupuis N; Krämer N; Cong XJ; Gibson N; Solca F; Ehrnrooth E; Machiels JH Ann Oncol; 2017 Oct; 28(10):2526-2532. PubMed ID: 28961833 [TBL] [Abstract][Full Text] [Related]
51. High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors. Brockton N; Dort J; Lau H; Hao D; Brar S; Klimowicz A; Petrillo S; Diaz R; Doll C; Magliocco A Int J Radiat Oncol Biol Phys; 2011 May; 80(1):249-57. PubMed ID: 21300470 [TBL] [Abstract][Full Text] [Related]
52. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study. Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107 [TBL] [Abstract][Full Text] [Related]
53. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL; Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422 [TBL] [Abstract][Full Text] [Related]
54. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site. Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345 [TBL] [Abstract][Full Text] [Related]
55. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222 [TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use. Murthy V; Swain M; Teni T; Pawar S; Kalkar P; Patil A; Chande A; Ghonge S; Laskar SG; Gupta T; Budrukkar A; Agrawal J Indian J Cancer; 2016; 53(3):387-393. PubMed ID: 28244466 [TBL] [Abstract][Full Text] [Related]
57. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC. Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101 [TBL] [Abstract][Full Text] [Related]
58. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
59. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089 [TBL] [Abstract][Full Text] [Related]
60. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas. Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]